Quick summary

Type of Medicine

Generic

Active Ingredient

Effective Within

Works By

Side Effects

Product details

Description

Levonorgestrel / Ethinylestradiol 0.15 / 0.03 mg is a combined oral contraceptive pill used to effectively and reversibly prevent pregnancy. It is a prescription medication intended for women who want a reliable and convenient daily method of contraception.

This pill contains two hormones, ethinylestradiol and levonorgestrel, which work together to prevent ovulation and create conditions that are unfavourable for fertilisation. When taken correctly and consistently, it provides a high level of contraceptive protection

In addition to preventing pregnancy, it may help regulate the menstrual cycle, reduce menstrual pain, and make periods lighter. For optimal results, it should be used in accordance with the advice of your healthcare professional.

Why choose weight loss medications?

GLP-1 receptor agonists are transforming the way we approach weight loss. Originally developed to help people with type 2 diabetes, these medications have since gained widespread approval for their effectiveness in weight management.

GLP-1 weight loss treatments work by mimicking natural hormones that help regulate appetite, slow digestion, and promote a feeling of fullness. Making it easier to reduce caloric intake and support sustainable weight loss.

Discover our Treatments

Proven results, backed by science

Weight loss medications targeting GLP-1 receptors offer clinically proven results for individuals with obesity or weight-related health issues. These treatments are not quick fixes. They are part of a long-term medical strategy designed to support a healthier lifestyle.

By reducing hunger signals and increasing feelings of fullness, GLP-1 therapies can help patients lose a significant percentage of their body weight when combined with lifestyle changes.

For those who have had limited success with diet and exercise alone, GLP-1–based products represent a modern and effective alternative, approved by regulatory authorities across the US.

Start your Consultation

FAQs

Please read our FAQs page to find out more.

Didn’t find your answer?

Don't hestitate to contact us